133 related articles for article (PubMed ID: 15613421)
21. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
22. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
23. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.
Grinspoon S; Miller K; Herzog D; Clemmons D; Klibanski A
J Clin Endocrinol Metab; 2003 Mar; 88(3):1142-9. PubMed ID: 12629097
[TBL] [Abstract][Full Text] [Related]
24. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
[TBL] [Abstract][Full Text] [Related]
25. Testosterone for low libido in postmenopausal women not taking estrogen.
Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
[TBL] [Abstract][Full Text] [Related]
26. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
27. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
[TBL] [Abstract][Full Text] [Related]
28. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.
Weinbrenner T; Zittermann A; Gouni-Berthold I; Stehle P; Berthold HK
Eur J Clin Nutr; 2003 Oct; 57(10):1262-7. PubMed ID: 14506487
[TBL] [Abstract][Full Text] [Related]
29. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism.
Misra M; Miller KK; Almazan C; Ramaswamy K; Lapcharoensap W; Worley M; Neubauer G; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2004 Oct; 89(10):4972-80. PubMed ID: 15472193
[TBL] [Abstract][Full Text] [Related]
30. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren JL; Braunstein GD; Simon JA; Casson PR; Buster JE; Redmond GP; Burki RE; Ginsburg ES; Rosen RC; Leiblum SR; Caramelli KE; Mazer NA
N Engl J Med; 2000 Sep; 343(10):682-8. PubMed ID: 10974131
[TBL] [Abstract][Full Text] [Related]
31. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
Grinspoon SK; Friedman AJ; Miller KK; Lippman J; Olson WH; Warren MP
J Clin Endocrinol Metab; 2003 Aug; 88(8):3651-6. PubMed ID: 12915650
[TBL] [Abstract][Full Text] [Related]
32. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
Guo CY; Jones TH; Eastell R
J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
[TBL] [Abstract][Full Text] [Related]
33. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
Young NR; Baker HW; Liu G; Seeman E
J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
[TBL] [Abstract][Full Text] [Related]
34. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
[TBL] [Abstract][Full Text] [Related]
35. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of androgens and estrogens on bone turnover in normal men.
Leder BZ; LeBlanc KM; Schoenfeld DA; Eastell R; Finkelstein JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):204-10. PubMed ID: 12519853
[TBL] [Abstract][Full Text] [Related]
38. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
Aging Male; 2012 Mar; 15(1):14-21. PubMed ID: 22092151
[TBL] [Abstract][Full Text] [Related]
39. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
[TBL] [Abstract][Full Text] [Related]
40. Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Gianatti EJ; Dupuis P; Hoermann R; Zajac JD; Grossmann M
J Clin Endocrinol Metab; 2014 Oct; 99(10):3821-8. PubMed ID: 24978674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
